Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
501
Effects of BM-MSCs on different types of lung cell death in different group.
Published 2025Subjects: -
502
-
503
-
504
-
505
-
506
Transcription and expression levels of CK8 in Caco-2 cells after CK8 gene was knocked down.
Published 2025Subjects: -
507
-
508
-
509
-
510
-
511
Statistical analysis of adhesiveness, hardness, and cohesiveness across IDDSI levels.
Published 2025Subjects: -
512
Significant gene set results from EGSEA.
Published 2024“…<p>The significant gene sets returned by EGSEA analysis of serum-deprived ARPE-19 cell differentially expressed genes. …”
-
513
-
514
Comparison of gut microbial composition at the phylum level pre- and post-surgery.
Published 2025Subjects: -
515
-
516
-
517
Levels of OVA-specific IgE and IgG1 in serum from different groups of mice.
Published 2025Subjects: -
518
-
519
-
520
Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. Monocytes and NK cells purified from PBMC collected from 10 RZV recipients (demographics in S4 Table) before vaccination (D0) and 90 days post-vaccination (D90) were combined ex vivo and stimulated with VZV-rgE. A subset of D0 monocyte & NK cocultures was also treated with the TGFβ1 inhibitor LY (D0 LY), and a subset of D90 cocultures were supplemented with rhTGFβ1. The graph shows individual data points, means and p values calculated by Friedman test for repeated measures with FDR correction. LY treatment of cells collected on D0 significantly increased their activation to levels similar to D90. Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.
Published 2025“…Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.…”